• Home
  • NEW DAY MEDICINE
  • 4(32)2020
  • 62 -4 (32/2) 2020 — Yangieva N.R., Tuychibaeva D.M. — PROPHYLACTICS DRY AGE-RELATED MACULAR DEGENERATION WITH VITAMIN-MINERAL COMPLEX

62 -4 (32/2) 2020 — Yangieva N.R., Tuychibaeva D.M. — PROPHYLACTICS DRY AGE-RELATED MACULAR DEGENERATION WITH VITAMIN-MINERAL COMPLEX

PROPHYLACTICS DRY AGE-RELATED MACULAR DEGENERATION WITH VITAMIN-MINERAL COMPLEX

Yangieva N.R. -Tashkent State Dental Institute

Tuychibaeva D.M. -Tashkent State Dental Institute

Resume

Age-related macular degeneretation is the major cause of blinness in developed world nations. Aim: to evaluate the clinical effectiveness of vitamin-mineral complex in the treatment of patients with dry of age-related macular degeneration. This was a controlled clinical trial that included 34 patients from the study group and 39 patients from the control group. There was a slight increase in visual acuity in patients from the study group, who consumed one capsule of Vitamin-mineral complex once a day per 3 months, per 3 yea. At the same time, there was a slight deterioration in visual acuity of patients in the control group, who did not take any vitamin-mineral complexes. Also, patients from the control group witnessed the ARMD progression, which was manifested as deterioration of the ARMD category. Patients in the ‘Vitamin- mineral complex” group had a decrease in the thickness of the macula within 3 mm zone, based on OCT, and experienced improvement in the subjective perception of the state of their visual functions compared to the patients from the control group in whom negative dynamics were detected. Prescription of Vitamin- mineral complex to the patients with dry AMD has a beneficial effect on the state of their visual functions, reduction of macula swelling and subjective perception of central vision, compared with the patients who did not take any vitamin- mineral complexes.

Key words: age-related macular degeneration, vitamins, minerals, lutein.

First page

265

Last page

270

For citation: Yangieva N.R., Tuychibaeva D.M., Prophylactics dry age-related macular degeneration with vitamin-mineral complex//New Day in Medicine 4(32)2020 265-270 https://cutt.ly/KzwuvFJ

List of References

  1. Юсупов А.Ф. Комплексная оценка функционального состоя­ния глаза при возрастной макулярной дегенерации и выбор тактики лечения. Автореферат на соискание ученой степени доктора медицинских наук, Ташкент. 2018. 23 стр.
  2. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta-carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2011; 119:1417-1436.
  3. Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005-2015.
  4. Aronow M.E., Chew E.Y. Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions // Curr Opin Ophthalmol. 2014. № 25. P.186-190.
  5. Bradley D.T., Zipfel P.F., Hughes A.E. Complement in age- related macular degeneration: a focus on function // Eye. 2011. № 25. P.683-693.
  6. Buscemi S., Corleo D., Di Pace F., Petroni M.L., Satriano A., Marchesini G. The Effect of Lutein on Eye and Extra-Eye Health // 2018. Doi: 10.3390/nu10091321.
  7. Damico F.M., Gasparin F., Scolari M.R, Pedral L.S., Takahashi B.S. New approaches and potential treatments for dry age-related macular degeneration // Arq Bras Oftalmol. 2012. №75 (1). P.71­76.
  8. Hogg R.E., Chakravarthy U. Visual function and dysfunction in early and late age-related maculopathy // Prog. Retin Eye Res. 2006. №25. P.249-76.
  9. Cougnard-Gregoire A. Vitamin D deficiency in community-dwelling elderly is not associated with age-related macular degeneration / Cougnard-Gregoire A., Benedicte MJ Merle, Jean-Francois Korobelnik J.F. // The Journal of Nutrition. – 2015. – Vol. 145(8). – P. 56-64.
  10. Capogna L., Pelletier M.B. Age-Related Eye Disease Study 2 (AREDS2) // Optometry. 2013 Available at: http://HYPERLINK “http://hyperlink%20%22http//www.allaboutvision.com/ nutrition/lutein.htm%22www.allaboutvision.com/nutrition/ lutein.htm”www.allaboutvision.com/nutrition/lutein.htm
  11. Jonas J.B., Cheung C.M., Panda-Jonas S. Updates on the Epidemiology of Age-Related Macular Degeneration. The Asia- Pacific Journal of Ophthalmology. 2017;6(6):493-497. DOI: 10.22608/APO.2017251
  12. Ma L., Dou H.L., Huang Y.M. Et al. Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial //Am. J. Ophthalmol. 2012. № 154. P.625­634.
  13. McBee W.L., Lindblad A.S., Ferris F.L. Who should receive oral supplement treatment for age-related macular degeneration? // Cochrane Database Syst Rev. 2017. 7:CD000254.
  14. Miller J.W. Age-Related Macular Degeneration revisited – piecing the puzzle: The LXIX Edward Jackson Memorial Lecture // Am. J. Ophthalmol. – 2013. – Vol. 155 (1). – P. 47-54.
  15. Parisi V., Tedeschi M., Gallinaro G., Varano M., Saviano S., Piermarocchi S. Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year // Ophthalmology. 2008. №115 (7). P.324-333.
  16. Schmier J.K., Covert D.W., Lau E.C. Patterns and costs associated with progression of age-related macular degeneration // Am. J. Ophthalmol. 2012. №154. P.675-681.
  17. Souied E.H., Delcourt C., Querques G. Et al. Oral Docosahexaenoic acid in the prevention of exudative agerelated macular degeneration: the nutritional AMD Treatment 2 Study. Ophthalmology. 2013. doi:10.1016/j.ophtha.
  18. Baiyrkhanova A., Ismailova A., Botabekova T., Enin E., Semenova Y. Crosslinked Chitosan / PVA film, suturated with 5- Fluorouracil for the prevention of proliferative vitreoretinopathy // Internal Journal of Drug Delivery Technology. 2016. №2 (6). P. 561-574.
  19. Wong P., Markey M., Rapp C.M., Darrow R.M., Ziesel A., Organisciak D.T. Enhancing the efficacy of AREDS antioxidants in light-induced retinal degeneration // Mol Vis. 2017. №10. P.718-739.
  20. Wong W.T., Kam W., Cunningham D. Treatment of geographic atrophy by the topical administration of OT- 551: results of a phase II clinical trial // Invest Ophthalmol Vis Sci. 2010. №51 (12). P.6131-6139.
62-265-270-4-32-2020-тиббиёт-25-12-2020-—-копия

file

download